CME Group

At a glance

CME Group reported 2025 revenue of $6.52B, up 6.4% from $6.13B in 2024. Over 4 years since 2021 ($4.69B), that is growth of about 8.6% a year. Operating margin was 64.9%, up from 56.4% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 12 insiders reported 4 open-market purchases ($667K) and 16 sales ($32.7M). 2 of the sales were made under pre-arranged 10b5-1 plans. The largest was a sale of $10.4M by Chairman and CEO Terrence A Duffy on May 18, 2026. Net, insiders were sellers of $32.1M.

CME Group filed 12 current reports (Form 8-K) in the last 12 months, most often for results of operations (4), officer or director change (2), regulation fd disclosure (2) and shareholder vote results (2). The latest officer or director change was reported on Sep 9, 2026. It reported a material agreement or a completed acquisition or disposal 1 time.

5 of the 20 investors tracked here held CME Group at the last quarter end, worth $360.9M combined. It is the largest weight for Baupost Group (2.5% of its portfolio), followed by Renaissance Technologies (0.2%). New this quarter: Baupost Group and Viking Global Investors. Added: Renaissance Technologies and National Pension Service (Korea).

Annual results

Fiscal year ends Dec 31 · incorporated in DE

Tracked investors holding (13F)

Weight is the share of each investor's portfolio, as of the quarter end.